Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingshuo Meng

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bio-Protocol|July 21, 2021
Intra-amniotic Injection of Mouse EmbryosLiyuan Cui, Peng Zou, Qingshuo Meng, et al.
Theranostics|March 4, 2017
Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte MembranesJinghan Su, Huiping Sun, Qingshuo Meng, et al.
Frontiers in Neuroscience|March 15, 2021
Tracking Eye Movements During Sleep in MiceQingshuo Meng, Xinrong Tan, Chengyong Jiang, et al.
Theranostics|February 28, 2020
Erratum: Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: ErratumJinghan Su, Huiping Sun, Qingshuo Meng, et al.
Molecular Pharmaceutics|November 19, 2013
iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistanceJianan Shen, Qingshuo Meng, Huiping Sui, et al.
Chemical Communications (Cambridge, England)|November 4, 2017
Chemical antagonism between photodynamic agents and chemotherapeutics: mechanism and avoidanceQingshuo Meng, Jia Meng, Wei Ran, et al.
Molecular Pharmaceutics|February 6, 2014
Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNAJianan Shen, Huiping Sun, Qingshuo Meng, et al.
ACS Nano|February 21, 2018
Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast CancerQingshuo Meng, Jia Meng, Wei Ran, et al.
Journal of Pharmaceutical Sciences|November 3, 2018
Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development InterfaceStephanie Dodd, Sivacharan Kollipara, Manuel Sanchez-Felix, et al.
Biomaterials|June 6, 2014
Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasisPengfei Xu, Haijun Yu, Zhiwen Zhang, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bio-Protocol|July 21, 2021
Intra-amniotic Injection of Mouse EmbryosLiyuan Cui, Peng Zou, Qingshuo Meng, et al.
Theranostics|March 4, 2017
Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte MembranesJinghan Su, Huiping Sun, Qingshuo Meng, et al.
Frontiers in Neuroscience|March 15, 2021
Tracking Eye Movements During Sleep in MiceQingshuo Meng, Xinrong Tan, Chengyong Jiang, et al.
Theranostics|February 28, 2020
Erratum: Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: ErratumJinghan Su, Huiping Sun, Qingshuo Meng, et al.
Molecular Pharmaceutics|November 19, 2013
iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistanceJianan Shen, Qingshuo Meng, Huiping Sui, et al.
Chemical Communications (Cambridge, England)|November 4, 2017
Chemical antagonism between photodynamic agents and chemotherapeutics: mechanism and avoidanceQingshuo Meng, Jia Meng, Wei Ran, et al.
Molecular Pharmaceutics|February 6, 2014
Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNAJianan Shen, Huiping Sun, Qingshuo Meng, et al.
ACS Nano|February 21, 2018
Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast CancerQingshuo Meng, Jia Meng, Wei Ran, et al.
Journal of Pharmaceutical Sciences|November 3, 2018
Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development InterfaceStephanie Dodd, Sivacharan Kollipara, Manuel Sanchez-Felix, et al.
Biomaterials|June 6, 2014
Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasisPengfei Xu, Haijun Yu, Zhiwen Zhang, et al.
Pageof 3